The new design manifests itself as a symbol for Innovation and excellence and marks the beginning of a new era for the company in the digital health industry. With the introduction of the modern look, Crossinvestics® recommits itself to being a leader in the areas of Pharmacovigilance monitoring and Social Media Monitoring The focus on evalii®, an advanced tool for social media and drug safety monitoring, is particularly highlighted. 

“Our new look is more than just a visual change,” explains Petra Dökel, Managing Director of the Crossinvestics® innovations group. “It represents our deep commitment to quality, efficiency and trust, and it strengthens our ambition to develop and offer innovative technical solutions for the pharmaceutical industry.” 

To celebrate the re-orientation, Crossinvestics® has also completely redesigned its C4C website, which now offers improved user guidance and expanded content to provide customers with a seamless experience. The website acts as a central point of contact for information and services specifically tailored to the needs of the modern pharmaceutical and healthcare industry. 

The innovations underline Crossinvestics®’s core competencies in the areas of social media and pharmacovigilance monitoring as well as its know-how for special technical solutions in the healthcare sector. 

“The digital transformation of the healthcare industry offers enormous opportunities and challenges. With our new appearance, we are well prepared to master these and actively shape the future of healthcare,” adds Philipp Petersen, founder of the Crossinvestics® innovations group added. 

Crossinvestics® invites customers, partners and interested parties to explore the new website and become part of the exciting journey to shape the innovations of tomorrow. "Together we shape the future. Today. Tomorrow." is the group's promise. 

For more information, please visit the C4C website at: www.cross4channel.com  

Der Beitrag Crossinvestics® innovations group startet mit frischem Design in die digitale Zukunft der Gesundheitsbranche  erschien zuerst auf Crossinvestics® GmbH.

evalii® has been specifically developed to help pharmaceutical companies comply with legal regulations while optimizing communication with customers or those affected via digital channels. Using artificial intelligence, the system automatically classifies messages according to their relevance to pharmacovigilance and documents them within seconds. One of evalii®'s highly qualified and specially trained employees then processes the data sets prepared by the system. These experts (from the fields of medicine, pharmacy, veterinary sciences and biochemistry, among others) carefully review the content and make informed decisions about how to handle the information. This process ensures that all pharmacovigilance-relevant data is not only recorded, but also evaluated and processed in accordance with regulatory requirements and taking the clinical context into account. This combination of automated detection and manual expertise enables our customers to rely on the quality and compliance of their pharmacovigilance activities.

The 24/7 monitoring of digital channels such as Facebook, Instagram, Twitter, YouTube and many others makes it possible to scan all posts and comments around the clock and document them accordingly.

"Our goal in developing evalii® was to create a solution that is not only efficient and compliant with data protection regulations, but also meets the regulatory requirements of pharmacovigilance monitoring. evalii®'s monitoring and moderation functions also make it possible to respond to contributions in accordance with the individual specifications of pharmaceutical companies," says Andrea Kurz, pharmacist and Head of Operations at Cross4Channel GmbH.

The new website provides detailed information about the system's functionalities and benefits, including continuous monitoring and reporting of social media posts, compliance with legal frameworks, and a data center that meets the ISO 27001 standard.

evalii® is available in almost all languages and thus offers broad international coverage, which is particularly important for globally operating pharmaceutical companies.

For more information please visit evalii.de or contact our support team at info@cross4channel.de.

Der Beitrag Cross4Channel® relauncht evalii.de – Die Website zur innovativen Plattform für Pharmakovigilanz-Monitoring und Social Media Moderation erschien zuerst auf Crossinvestics® GmbH.